[1] |
Fatty Liver Expert Committee, Chinese Medical Doctor Association, National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association. Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update[J]. J Clin Hepatol, 2018, 34(5): 939-946. DOI: 10.3969/j.issn.1001-5256.2018.05.006.
中国医师协会脂肪性肝病专家委员会, 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 939-946. DOI: 10.3969/j.issn.1001-5256.2018.05.006.
|
[2] |
SILVA-ISLAS CA, MALDONADO PD. Canonical and non-canonical mechanisms of Nrf2 activation[J]. Pharmacol Res, 2018, 134: 92-99. DOI: 10.1016/j.phrs.2018.06.013.
|
[3] |
SHAW P, CHATTOPADHYAY A. Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms[J]. J Cell Physiol, 2020, 235(4): 3119-3130. DOI: 10.1002/jcp.29219.
|
[4] |
ZHANG A, SUZUKI T, ADACHI S, et al. Distinct regulations of HO-1 gene expression for stress response and substrate induction[J]. Mol Cell Biol, 2021, 41(11): e0023621. DOI: 10.1128/MCB.00236-21.
|
[5] |
RYTER SW. Heme oxygenase-1: An anti-inflammatory effector in cardiovascular, lung, and related metabolic disorders[J]. Antioxidants (Basel), 2022, 11(3): 555. DOI: 10.3390/antiox11030555.
|
[6] |
ZHOU J, ZHENG Q, CHEN Z. The Nrf2 pathway in liver diseases[J]. Front Cell Dev Biol, 2022, 10: 826204. DOI: 10.3389/fcell.2022.826204.
|
[7] |
SHERIFF L, KHAN RS, SABORANO R, et al. Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than Nrf2-/- animals[J]. Dis Model Mech, 2020, 13(12): dmm046383. DOI: 10.1242/dmm.046383.
|
[8] |
WANG G, FU Y, LI J, et al. Aqueous extract of Polygonatum sibiricum ameliorates ethanol-induced mice liver injury via regulation of the Nrf2/ARE pathway[J]. J Food Biochem, 2021, 45(1): e13537. DOI: 10.1111/jfbc.13537.
|
[9] |
WANG X, CHANG X, ZHAN H, et al. Curcumin and Baicalin ameliorate ethanol-induced liver oxidative damage via the Nrf2/HO-1 pathway[J]. J Food Biochem, 2020. DOI: 10.1111/jfbc.13425.[Online ahead of print]
|
[10] |
FERDOUSE A, CLUGSTON RD. Pathogenesis of alcohol-associated fatty liver: lessons from transgenic mice[J]. Front Physiol, 2022, 13: 940974. DOI: 10.3389/fphys.2022.940974.
|
[11] |
OSNA NA, DONOHUE TM Jr, KHARBANDA KK. Alcoholic liver disease: pathogenesis and current management[J]. Alcohol Res, 2017, 38(2): 147-161.
|
[12] |
SEEN S. Chronic liver disease and oxidative stress - a narrative review[J]. Expert Rev Gastroenterol Hepatol, 2021, 15(9): 1021-1035. DOI: 10.1080/17474124.2021.1949289.
|
[13] |
CHEN WY, SHU FM, WANG H, et al. Role of the cytochrome P450 family in metabolic-associated liver diseases[J]. J Chin Hepatol, 2022, 38(9): 2182-2187. DOI: 10.3969/j.issn.1001-5256.2022.09.045.
陈玮钰, 舒发明, 王涵, 等. 细胞色素P450家族在肝脏代谢相关疾病中的作用[J]. 临床肝胆病杂志, 2022, 38(9): 2182-2187. DOI: 10.3969/j.issn.1001-5256.2022.09.045.
|
[14] |
WU KC, LIU J, KLAASSEN CD. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation[J]. Toxicol Appl Pharmacol, 2012, 262(3): 321-329. DOI: 10.1016/j.taap.2012.05.010.
|
[15] |
PALIPOCH S, KOOMHIN P, PUNSAWAD C, et al. Heme oxygenase-1 alleviates alcoholic liver steatosis: histopathological study[J]. J Toxicol Pathol, 2016, 29(1): 7-15. DOI: 10.1293/tox.2015-0035.
|
[16] |
BUKO V, ZAVODNIK I, BUDRYN G, et al. Chlorogenic acid protects against advanced alcoholic steatohepatitis in rats via modulation of redox homeostasis, inflammation, and lipogenesis[J]. Nutrients, 2021, 13(11). DOI: 10.3390/nu13114155.
|
[17] |
TOROK NJ. Update on alcoholic hepatitis[J]. Biomolecules, 2015, 5(4): 2978-2986. DOI: 10.3390/biom5042978.
|
[18] |
HOSSEINI N, SHOR J, SZABO G. Alcoholic hepatitis: a review[J]. Alcohol Alcohol, 2019, 54(4): 408-416. DOI: 10.1093/alcalc/agz036.
|
[19] |
RAMOS-TOVAR E, MURIEL P. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage[J]. J Appl Toxicol, 2020, 40(1): 151-168. DOI: 10.1002/jat.3880.
|
[20] |
GALICIA-MORENO M, LUCANO-LANDEROS S, MONROY-RAMIREZ HC, et al. Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects[J]. Antioxidants (Basel), 2020, 9(10): 980. DOI: 10.3390/antiox9100980.
|
[21] |
HONG DG, SONG GY, EOM CB, et al. Loss of ERdj5 exacerbates oxidative stress in mice with alcoholic liver disease via suppressing Nrf2[J]. Free Radic Biol Med, 2022, 184: 42-52. DOI: 10.1016/j.freeradbiomed.2022.03.027.
|
[22] |
RYTER SW. Heme oxgenase-1, a cardinal modulator of regulated cell death and inflammation[J]. Cells, 2021, 10(3): 515. DOI: 10.3390/cells10030515.
|
[23] |
LIU S, TIAN L, CHAI G, et al. Targeting heme oxygenase-1 by quercetin ameliorates alcohol-induced acute liver injury via inhibiting NLRP3 inflammasome activation[J]. Food Funct, 2018, 9(8): 4184-4193. DOI: 10.1039/c8fo00650d.
|
[24] |
ZHANG Y, WU Y, SHEN W, et al. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review)[J]. Mol Med Rep, 2022, 25(6): 208. DOI: 10.3892/mmr.2022.12724.
|
[25] |
LI T, LIU HB, HU WY, et al. Role of inflammation in hepatic fibrosis[J]. J Clin Hepatol, 2022, 38(10): 2368-2372. DOI: 10.3969/j.issn.1001-5256.2022.10.032.
李婷, 刘华宝, 胡文艳, 等. 炎症在肝纤维化中的作用[J]. 临床肝胆病杂志, 2022, 38(10): 2368-2372. DOI: 10.3969/j.issn.1001-5256.2022.10.032.
|
[26] |
CHENG ML, LU YF, CHEN H, et al. Liver expression of Nrf2-related genes in different liver diseases[J]. Hepatobiliary Pancreat Dis Int, 2015, 14(5): 485-491. DOI: 10.1016/s1499-3872(15)60425-8.
|
[27] |
NUNES DOS SANTOS K, FLORENTINO RM, FRANÇA A, et al. Polymorphism in the promoter region of NFE2L2 gene is a genetic marker of susceptibility to cirrhosis associated with alcohol abuse[J]. Int J Mol Sci, 2019, 20(14): 3589. DOI: 10.3390/ijms20143589.
|
[28] |
NI YH, HUO LJ, LI TT. Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22[J]. World J Gastroenterol, 2017, 23(11): 2002-2011. DOI: 10.3748/wjg.v23.i11.2002.
|
[29] |
LIU Y, KUANG Q, DAI X, et al. Deficiency in inactive rhomboid protein2 (iRhom2) alleviates alcoholic liver fibrosis by suppressing inflammation and oxidative stress[J]. Int J Mol Sci, 2022, 23(14): 7701. DOI: 10.3390/ijms23147701.
|
[30] |
YANG H, ZHANG L, CHEN J, et al. Heme oxygenase-1 inhibits the proliferation of hepatic stellate cells by activating PPARγ and suppressing NF-κB[J]. Comput Math Methods Med, 2022, 2022: 8920861. DOI: 10.1155/2022/8920861.
|
[31] |
BUCHANAN R, SINCLAIR J. Alcohol use disorder and the liver[J]. Addiction, 2021, 116(5): 1270-1278. DOI: 10.1111/add.15204.
|
[32] |
GANNE-CARRIÉ N, NAHON P. Hepatocellular carcinoma in the setting of alcohol-related liver disease[J]. J Hepatol, 2019, 70(2): 284-293. DOI: 10.1016/j.jhep.2018.10.008.
|
[33] |
ZHANG C, LI L, HOU S, et al. Astragaloside Ⅳ inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways[J]. J Ethnopharmacol, 2021, 279: 114350. DOI: 10.1016/j.jep.2021.114350.
|
[34] |
ZOU C, ZOU C, CHENG W, et al. Heme oxygenase-1 retards hepatocellular carcinoma progression through the microRNA pathway[J]. Oncol Rep, 2016, 36(5): 2715-2722. DOI: 10.3892/or.2016.5056.
|
[35] |
RAGHUNATH A, SUNDARRAJ K, ARFUSO F, et al. Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance[J]. Cancers (Basel), 2018, 10(12): 481. DOI: 10.3390/cancers10120481.
|
[36] |
WU MM, HSIEH FI, HSU LI, et al. GT-repeat polymorphism in the HO-1 gene promoter Is associated with risk of liver cancer: a follow-up study from arseniasis-endemic areas in Taiwan[J]. J Clin Med, 2021, 10(7): 1489. DOI: 10.3390/jcm10071489.
|